Abstract:Gestational choriocarcinoma incidence rates have declined and survivals have improved, but blacks continue to have higher incidence and lower survival rates.
“…It is less likely that inadequacy of postmolar surveillance guidelines contributed significantly because clear guidelines exist for diagnosis of and surveillance after GTD. 15 Our results affirm many of the findings of an earlier SEER analysis by Smith et al, 9 who evaluated patients with choriocarcinoma from 1973 to 1999. Like these authors, we also showed that most patients with choriocarcinoma are diagnosed from ages 20 to 39 years and that there is no difference in the distribution of choriocarcinoma by stage and race.…”
Section: 048supporting
confidence: 85%
“…The analysis of age-adjusted cancer incidence, however, was limited to patients diagnosed from 2000 to 2014 because data from 1973 to 1999 have been previously evaluated. 9 Patients with choriocarcinoma were identified on the basis of their International Classification of Diseases for Oncology, Third Edition (ICD-O-3) code. 10 Patients with the histologic code for choriocarcinoma (9100/3) were included.…”
Section: Methodsmentioning
confidence: 99%
“…Like these authors, we also showed that most patients with choriocarcinoma are diagnosed from ages 20 to 39 years and that there is no difference in the distribution of choriocarcinoma by stage and race. 9 Their analysis also that showed that increasing age at diagnosis and advanced-stage disease were associated with worse survival. 9 Interestingly, although our study adds an additional 14 years of data, 5-year OS is almost identical for both studies (89.5% vs 89.6%).…”
Section: 048mentioning
confidence: 99%
“…9 Their analysis also that showed that increasing age at diagnosis and advanced-stage disease were associated with worse survival. 9 Interestingly, although our study adds an additional 14 years of data, 5-year OS is almost identical for both studies (89.5% vs 89.6%). 9 Our study provides new insight into the age-adjusted incidence of choriocarcinoma.…”
Most patients with choriocarcinoma have excellent prognosis. However, NHB patients and patients who are diagnosed at the age of at least 20 years or have distant stage have significantly worse mortality.
“…It is less likely that inadequacy of postmolar surveillance guidelines contributed significantly because clear guidelines exist for diagnosis of and surveillance after GTD. 15 Our results affirm many of the findings of an earlier SEER analysis by Smith et al, 9 who evaluated patients with choriocarcinoma from 1973 to 1999. Like these authors, we also showed that most patients with choriocarcinoma are diagnosed from ages 20 to 39 years and that there is no difference in the distribution of choriocarcinoma by stage and race.…”
Section: 048supporting
confidence: 85%
“…The analysis of age-adjusted cancer incidence, however, was limited to patients diagnosed from 2000 to 2014 because data from 1973 to 1999 have been previously evaluated. 9 Patients with choriocarcinoma were identified on the basis of their International Classification of Diseases for Oncology, Third Edition (ICD-O-3) code. 10 Patients with the histologic code for choriocarcinoma (9100/3) were included.…”
Section: Methodsmentioning
confidence: 99%
“…Like these authors, we also showed that most patients with choriocarcinoma are diagnosed from ages 20 to 39 years and that there is no difference in the distribution of choriocarcinoma by stage and race. 9 Their analysis also that showed that increasing age at diagnosis and advanced-stage disease were associated with worse survival. 9 Interestingly, although our study adds an additional 14 years of data, 5-year OS is almost identical for both studies (89.5% vs 89.6%).…”
Section: 048mentioning
confidence: 99%
“…9 Their analysis also that showed that increasing age at diagnosis and advanced-stage disease were associated with worse survival. 9 Interestingly, although our study adds an additional 14 years of data, 5-year OS is almost identical for both studies (89.5% vs 89.6%). 9 Our study provides new insight into the age-adjusted incidence of choriocarcinoma.…”
Most patients with choriocarcinoma have excellent prognosis. However, NHB patients and patients who are diagnosed at the age of at least 20 years or have distant stage have significantly worse mortality.
“…Deregulation in this pseudomalignant phenotype results in the development of GTDs [42] and PE [43] which involves excessive or shallow invasion of trophoblasts into myometrium, respectively. Recent studies have suggested existence of common epigenetic mechanisms between trophoblasts and cancer cells, regulating proliferative, migratory and invasive properties [40,44].…”
Deregulation of methylation of tumor suppressor genes contributes to the development of preeclampsia and gestational trophoblastic diseases. APC and PRKCDBP may act as fetal DNA epigenetic markers for prenatal diagnosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.